Pharmacokinetics and pharmacodynamic effects of ABT-627, an oral ETA selective endothelin antagonist, in humans

Similar Items

• Pharmacokinetics and pharmacodynamics of tezosentan, an intravenous dual endothelin receptor antagonist, following chronic infusion in healthy subjects
  od: Dingemanse, Jasper, i dr.
  Izdano: (2002)
• Organocatalytic Enantioselective Conjugate Addition of Nitromethane to Benzylidene-2-Benzoyl Acetate: Asymmetric Synthesis of ABT – 627, an Endothelin Receptor Antagonist
  od: Hajra, Saumen, i dr.
  Izdano: (2020)
• Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan
  od: Sidharta, P. N., i dr.
  Izdano: (2015)
• Vasodilator effects of the endothelin ET(A) receptor selective antagonist BMS-193884 in healthy men
  od: Dhaun, Neeraj, i dr.
  Izdano: (2005)
• Co-administration of ketoconazole with H(1)-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects
  od: Chaikin, P, i dr.
  Izdano: (2005)